Preprints202403 0433 v1

Review Not peer-reviewed version
Artificial Intelligence (AI) and Machine

Learning (ML) in Diagnosing Cancer:
Current Trends
Mohammad Odah *
Posted Date: 7 March 2024
doi: 10.20944/preprints202403.0433.v1
Keywords: Artificial Intelligence; Machine Learning; Cancer Diagnosis; Precision Medicine; Data Privacy;
Regulatory Frameworks
Preprints.org is a free multidiscipline platform providing preprint service that

is dedicated to making early versions of research outputs permanently
available and citable. Preprints posted at Preprints.org appear in Web of
Science, Crossref, Google Scholar, Scilit, Europe PMC.
Copyright: This is an open access article distributed under the Creative Commons
Attribution License which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
Preprints.org (www.preprints.org) | NOT PEER-REVIEWED | Posted: 7 March 2024 doi:10.20944/preprints202403.0433.v1
Disclaimer/Publisher’s Note: The statements, opinions, and data contained in all publications are solely those of the individual author(s) and
contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting
from any ideas, methods, instructions, or products referred to in the content.
Review
Artificial Intelligence (AI) and Machine Learning (ML)

in Diagnosing Cancer: Current Trends
Mohammad Ahmad Ahmad Odah *
Prince Sattam Bin Abdulaziz University, Preparatory Year Deanship, Basic Science Department, 151 Alkharj
11942, KSA
* Correspondence: [email protected] ; Tel: +966-55 820 2366.
Abstract: Cancer diagnosis stands at the cusp of a profound transformation, driven by the burgeoning
capabilities of Artificial Intelligence (AI) and Machine Learning (ML). This comprehensive review illuminates
the extraordinary impact of AI and ML in the field, unraveling their multifaceted roles in the realm of oncology.
In the arena of cancer diagnosis, AI and ML serve as invaluable allies, empowering healthcare professionals
with unparalleled tools for precision and efficiency. Notably, AI’s prowess in analyzing medical images,
including radiological scans and pathology slides, elevates the early detection of malignancies to new heights.
Coupled with its ability to dissect genomic data, AI tailors therapeutic strategies to the individual, promising
optimized treatment outcomes. However, the incorporation of AI and ML into clinical practice necessitates a
careful navigation of ethical considerations, data privacy, and regulatory landscapes. Safeguarding patient
data, ensuring transparency, and addressing algorithmic biases emerge as pivotal challenges that require
vigilant attention. Yet, the future of AI and ML in cancer diagnosis is brimming with promise. The integration
of multi-modal data, real-time monitoring, and Explainable AI (XAI) methods holds the potential to enrich
diagnostic capabilities and engender patient trust. Global collaboration and data sharing initiatives are
fostering the development of robust AI models. Furthermore, AI’s role in cancer prevention, identifying high-
risk individuals and enabling targeted preventive strategies, is poised to revolutionize healthcare. AI and ML
are forging a path toward an era of unparalleled accuracy, efficiency, and personalization in cancer diagnosis.
Challenges notwithstanding, these technologies bear the promise of fundamentally reshaping patient care,
elevating outcomes, and advancing the fight against cancer. The ongoing exploration and responsible
implementation of AI and ML in oncology will be pivotal in harnessing their full potential and paving the way
for a brighter future for cancer patients.
Keywords: artificial intelligence; machine learning; cancer diagnosis; precision medicine;

data privacy; regulatory frameworks
1. Introduction
Cancer, a complex and heterogeneous group of diseases, poses a formidable challenge to
modern medicine. The early and accurate diagnosis of cancer is paramount for improving patient
outcomes, as it allows for timely intervention and personalized treatment strategies. In recent years,
the integration of Artificial Intelligence (AI) and Machine Learning (ML) has emerged as a
transformative force in the field of healthcare [1]. Specifically, AI and ML techniques have shown
remarkable potential in revolutionizing cancer diagnosis, offering innovative solutions that augment
the capabilities of healthcare professionals and researchers alike [2].
The marriage of AI and ML with cancer diagnosis is underpinned by their ability to rapidly
analyze vast and diverse datasets. From medical images and genomic profiles to clinical records,
these technologies have demonstrated an unparalleled capacity to process and interpret data [3].
Consequently, AI and ML have paved the way for a new era in oncology, where advanced algorithms
can detect malignancies, predict disease progression, and assist in tailoring treatment strategies on
an individual basis [4].
© 2024 by the author(s). Distributed under a Creative Commons CC BY license.

This review article seeks to provide an extensive examination of the current trends in AI and ML
applications for cancer diagnosis, offering insights into the profound impact of these technologies on
the field. Our comprehensive analysis will encompass various dimensions:
Methodologies and Algorithms: We will begin by delving into the cutting-edge methodologies
and algorithms that drive AI and ML-based cancer diagnosis. From deep learning techniques to
ensemble models, we will explore the technical underpinnings of these advancements [5].
Clinical Implementations: Our review will then turn its focus to the practical applications of AI
and ML in clinical settings. We will assess their effectiveness in diagnosing different cancer types,
such as breast cancer, lung cancer, and prostate cancer, while also examining their role in optimizing
treatment selection [6].
Challenges and Future Prospects: As AI and ML continue to evolve within the context of cancer
diagnosis, we will not only highlight their successes but also address the challenges they face. Ethical
concerns, data privacy, and regulatory considerations will be discussed, along with an exploration of
future directions in this rapidly evolving field [7].
By the conclusion of this review, readers will possess a comprehensive understanding of the
present landscape of AI and ML in cancer diagnosis. Our aim is to illuminate the transformative
potential of these technologies while acknowledging the complexities and considerations that
accompany their integration into the healthcare ecosystem. As AI and ML continue to shape the
future of oncology, this article serves as a valuable resource for researchers, healthcare professionals,
policymakers, and all those engaged in the pursuit of enhanced cancer diagnostics.
2. The Growing Impact of AI and ML in Cancer Diagnosis

In recent years, Artificial Intelligence (AI) and Machine Learning (ML) have catalyzed a
revolution in the field of cancer diagnosis [8]. These technologies have emerged as powerful tools
capable of processing and interpreting vast datasets with unparalleled speed and accuracy [9]. As a
result, they have begun to profoundly influence the landscape of oncological care, enhancing the
capabilities of healthcare professionals and researchers alike. AI and ML offer several advantages in
cancer diagnosis. They excel in the analysis of medical images, including radiological scans such as
mammograms, CT scans, and MRIs [10]. By automating the detection of anomalies and providing
quantitative assessments, AI-driven image analysis systems have significantly improved the early
diagnosis of cancers, such as breast cancer, where early detection is crucial [11].
Moreover, genomic profiling has become a cornerstone of modern cancer diagnosis and
treatment planning. AI and ML algorithms can sift through the immense complexity of genomic data
to identify genetic mutations and alterations associated with specific cancer types [12]. This ability
enables precision medicine approaches, where treatment strategies are tailored to the genetic profile
of individual patients, optimizing therapeutic outcomes [13]. Beyond image analysis and genomics,
AI and ML also play a pivotal role in the integration of clinical data. Electronic health records (EHRs)
and patient histories contain a wealth of information that, when analyzed with AI, can aid in
diagnosing cancer, predicting disease progression, and informing treatment decisions [14]. The
growing impact of AI and ML in cancer diagnosis is not limited to research laboratories; it is rapidly
permeating clinical practice. Diagnostic tools driven by AI algorithms are being deployed in
healthcare institutions worldwide, assisting radiologists, pathologists, and oncologists in their daily
routines [15]. The result is enhanced diagnostic accuracy, reduced diagnostic timeframes, and
improved patient outcomes.
However, the integration of AI and ML into cancer diagnosis is not without challenges. Ethical
concerns, data privacy issues, and the need for robust regulatory frameworks are topics that warrant
careful consideration [16]. These technologies also demand ongoing training and validation to ensure
their reliability and safety in clinical settings [17]. As AI and ML continue to evolve, they hold the
promise of further transforming the landscape of cancer diagnosis. This review article aims to delve
into these advancements, exploring the methodologies, clinical applications, challenges, and future
prospects of AI and ML in diagnosing cancer.
3. Methodologies and Algorithms
3.1. Harnessing Advanced Techniques: AI and ML in Cancer Diagnosis

The success of Artificial Intelligence (AI) and Machine Learning (ML) in cancer diagnosis hinges
on the sophisticated methodologies and algorithms at their core. These advanced techniques have
ushered in a new era of precision and efficiency in detecting and characterizing cancer. One of the
most significant advancements lies in deep learning, a subfield of ML that employs artificial neural
networks to analyze complex data [18]. Convolutional Neural Networks (CNNs) are particularly
noteworthy, excelling in image analysis tasks. In cancer diagnosis, CNNs have been employed to
interpret medical images such as mammograms, detecting subtle abnormalities that might elude the
human eye [19].
Ensemble methods, which combine multiple models to improve prediction accuracy, have also
gained prominence [20]. In the context of cancer diagnosis, ensemble techniques have demonstrated
their effectiveness in reducing false positives and negatives. Random Forests and Gradient Boosting,
for instance, have shown promise in analyzing genetic data for cancer risk assessment [21].
Furthermore, the utilization of Natural Language Processing (NLP) has unlocked the potential
of AI and ML in extracting valuable insights from unstructured clinical texts and electronic health
records [22]. These methodologies enable algorithms to extract meaningful information from patient
narratives, pathology reports, and medical literature, contributing to more comprehensive diagnostic
processes.
Another key innovation is Transfer Learning, where pre-trained models are adapted for specific
cancer types or tasks [23]. Transfer Learning accelerates the development of AI solutions for cancer
diagnosis by leveraging knowledge acquired from broader datasets, reducing the need for extensive
data labeling and model training.
Graph-based methods have also emerged as valuable tools for cancer diagnosis. Graph Neural
Networks (GNNs) can analyze the intricate relationships among various elements in cancer data,
such as genes, proteins, and diseases, aiding in uncovering hidden patterns and biomarkers [24].
In addition to these methodologies, the integration of Explainable AI (XAI) techniques is gaining
importance. Ensuring transparency and interpretability in AI and ML models is essential, especially
in healthcare. XAI methodologies facilitate the understanding of model predictions, enabling
clinicians to trust and utilize AI-driven diagnostic tools with confidence [25]. The methodologies and
algorithms discussed here represent only a fraction of the diverse toolkit available to researchers and
practitioners in the field of AI and ML in cancer diagnosis. These advanced techniques continue to
evolve, pushing the boundaries of what is possible in the quest for earlier and more accurate cancer
detection.
3.2. From Deep Learning to Ensemble Models: Technical Foundations

The technical foundations of AI and ML methodologies and algorithms employed in cancer
diagnosis encompass a wide array of techniques. This section explores the evolution from deep
learning to ensemble models, underpinning the progress in AI-driven cancer diagnosis [26].
3.2.1. Deep Learning: Unleashing Neural Networks

At the heart of many AI applications in cancer diagnosis lies deep learning, a subfield of ML
characterized by artificial neural networks. Deep neural networks, particularly Convolutional Neural
Networks (CNNs), have become instrumental in the analysis of medical images [27]. CNNs are adept
at identifying subtle patterns and anomalies in images, a critical aspect in early cancer detection. They
have been widely employed in the interpretation of radiological scans, including mammograms, X-
rays, and MRIs [28].
3.2.2. Transfer Learning: Leveraging Pre-trained Models

Transfer learning has emerged as a time-efficient approach to adapt pre-trained deep learning
models to the domain of cancer diagnosis [29]. By leveraging knowledge gained from extensive
datasets, transfer learning accelerates model development and reduces the need for massive amounts
of labeled data. This technique has demonstrated its utility in tasks such as classifying histopathology
slides or predicting cancer types based on gene expression profiles [30].
3.2.3. Ensemble Models: Combining Strengths

Ensemble learning methods have garnered attention for their ability to enhance prediction
accuracy. In the context of cancer diagnosis, these techniques combine multiple models to improve
the robustness and reliability of predictions [31]. Methods such as Random Forests and Gradient
Boosting have excelled in analyzing genomic data to identify genetic markers associated with specific
cancers [32]. Ensemble approaches help mitigate the risk of false positives and negatives, a critical
consideration in clinical settings.
3.2.4. Graph-Based Methods: Uncovering Complex Relationships

Graph Neural Networks (GNNs) have emerged as valuable tools for unraveling complex
relationships within cancer data [33]. In the realm of cancer, elements such as genes, proteins, and
diseases often exhibit intricate connections. GNNs can model these relationships, aiding in the
identification of hidden patterns, novel biomarkers, and potential therapeutic targets.
3.2.5. Explainable AI (XAI): Enhancing Interpretability

The integration of Explainable AI (XAI) techniques is crucial in healthcare, where trust and
interpretability are paramount [34]. XAI methods provide insights into why AI models make specific
predictions, ensuring that clinicians can understand and trust these models. Techniques such as LIME
(Local Interpretable Model-Agnostic Explanations) and SHAP (SHapley Additive exPlanations) help
shed light on the decision-making process of AI algorithms.
Collectively, these technical foundations serve as the building blocks for the AI and ML
methodologies and algorithms that are transforming cancer diagnosis. They empower healthcare
professionals and researchers to harness the potential of AI, driving progress toward more accurate,
efficient, and accessible cancer diagnostic tools.
4. Clinical Implementations
The integration of Artificial Intelligence (AI) and Machine Learning (ML) into clinical practice
has ushered in a new era in the diagnosis and management of cancer. These technologies are
transforming the landscape of oncological care by enhancing diagnostic accuracy, optimizing
treatment strategies, and providing valuable insights into disease-specific nuances.
4.1. Transforming Cancer Diagnosis: AI and ML in Clinical Practice

AI and ML are being deployed in clinical settings to augment the capabilities of healthcare
professionals in cancer diagnosis [35]. Radiologists, pathologists, and oncologists are increasingly
relying on AI-driven diagnostic tools to assist in their decision-making processes. These tools offer
several advantages, including the ability to analyze medical images with remarkable precision,
reducing the risk of oversight or misinterpretation [36]. For instance, AI-powered image analysis can
aid in the early detection of breast cancer by identifying subtle anomalies in mammograms [37].
Moreover, AI algorithms can assist in the evaluation of pathology slides, offering a second opinion
to pathologists and reducing the burden of manual examination [38].
4.2. Disease-Specific Insights: AI and ML in Breast, Lung, and Prostate Cancer Diagnosis
AI and ML have demonstrated exceptional capabilities in disease-specific cancer diagnosis. In
breast cancer, AI-powered mammography and ultrasound systems have shown promise in
identifying malignancies at an early stage [39]. These technologies assist radiologists by highlighting
suspicious areas and quantifying the likelihood of cancer. In lung cancer, AI has revolutionized the
interpretation of chest CT scans, offering rapid and accurate detection of nodules and lesions [40].
Additionally, AI algorithms can analyze genetic data to predict the risk of developing lung cancer,
enabling early intervention and preventive measures [41]. For prostate cancer, AI-driven image
analysis has improved the accuracy of prostate MRI interpretation, aiding in the identification of
clinically significant tumors [42]. AI can also assist in risk assessment and treatment planning for
prostate cancer patients, contributing to personalized care [43].
4.3. Personalized Treatment Strategies: AI’s Role in Therapy Optimization

AI’s capacity to analyze vast datasets, including patient medical histories and genomic profiles,
has paved the way for personalized treatment strategies in cancer care [44]. By considering the unique
characteristics of each patient’s disease, AI algorithms can assist oncologists in selecting the most
appropriate treatment regimen. This tailored approach enhances treatment efficacy while minimizing
side effects [45]. For example, AI-driven models can predict a patient’s response to specific
chemotherapy drugs based on genetic markers, enabling more precise treatment planning [46].
Additionally, AI supports the identification of potential clinical trial candidates, matching patients
with experimental therapies that align with their individual profiles [47].
The clinical implementations of AI and ML in cancer diagnosis are poised to revolutionize
patient care. By improving diagnostic accuracy, providing disease-specific insights, and optimizing
treatment strategies, these technologies are enhancing the quality of care and contributing to better
outcomes for cancer patients.
5. Challenges and Future Prospects

The integration of Artificial Intelligence (AI) and Machine Learning (ML) into cancer diagnosis
holds immense promise, but it is not without its challenges. This section explores ethical
considerations, data privacy concerns, regulatory landscapes, and the future directions of AI and ML
in the field.
5.1. Ethical Considerations and Data Privacy in AI-Driven Diagnostics

As AI and ML technologies become integral to healthcare, ethical considerations and data
privacy are paramount [48]. Patient data, including medical records and imaging, are sensitive and
must be handled with the utmost care. Ensuring data privacy and security is essential to maintain
patient trust and comply with regulatory frameworks [49]. The transparent and ethical use of AI in
decision-making processes is crucial. Researchers and healthcare providers must address questions
of algorithmic bias, accountability, and the potential for unintended consequences in patient care [50].
5.2. Navigating Regulatory Landscapes: AI and ML in Healthcare

The regulatory landscape for AI and ML in healthcare is evolving rapidly [51]. Regulatory bodies
around the world are working to establish guidelines and standards to ensure the safe and effective
use of these technologies [52]. AI-driven diagnostic tools must meet rigorous validation and
certification requirements before widespread adoption [53]. Navigating these regulatory pathways
presents challenges for both developers and healthcare institutions, but it is essential to ensure the
quality and safety of AI-driven diagnostics.
5.3. Beyond the Horizon: Future Directions in AI and ML for Cancer Diagnosis
The future of AI and ML in cancer diagnosis is a dynamic and promising frontier. Several
directions offer exciting prospects:
5.3.1. Multi-Modal Integration: Integrating data from various sources, including medical images,
genomic profiles, and clinical records, promises more comprehensive and accurate diagnoses [54].
5.3.2. Real-Time Monitoring: AI-driven tools that continuously monitor patient data for early signs
of cancer recurrence or treatment response offer the potential for proactive interventions [55].
5.3.3. Explainable AI (XAI): Advancements in XAI methods will enhance the interpretability of AI
models, enabling healthcare professionals to trust and understand the rationale behind AI-driven
recommendations [56].
5.3.4. Global Collaboration: International collaboration and data sharing initiatives will facilitate
the development of more robust AI models, transcending geographical boundaries [57].
5.3.5. Cancer Prevention: AI and ML can play a pivotal role in identifying individuals at high risk
of cancer based on genetic, lifestyle, and environmental factors, enabling targeted prevention
strategies [58].
While AI and ML offer transformative potential in cancer diagnosis, they also present ethical,
privacy, and regulatory challenges that must be addressed. Looking ahead, the future holds
promising developments in multi-modal integration, real-time monitoring, XAI, global collaboration,
and cancer prevention, ultimately advancing the field of cancer diagnosis and improving patient
outcomes.
Conclusion
In the rapidly evolving landscape of oncology, Artificial Intelligence (AI) and Machine Learning
(ML) have emerged as transformational forces, poised to shape the future of cancer diagnosis. This
review has illuminated the remarkable impact of AI and ML in several critical domains, underscoring
their potential to revolutionize patient care.
The growing impact of AI and ML in cancer diagnosis is evident in their ability to augment the
capabilities of healthcare professionals, enhancing diagnostic accuracy and speed. AI-driven
diagnostic tools are proving invaluable in the interpretation of medical images, including radiological
scans, enabling the early detection of cancers and minimizing the risk of oversight. Moreover, AI’s
proficiency in genomic profiling facilitates personalized treatment strategies, tailoring therapies to
individual patients’ genetic profiles and optimizing outcomes.
However, as AI and ML increasingly integrate into clinical practice, ethical considerations, data
privacy, and regulatory frameworks assume pivotal roles. Protecting patient data and ensuring
transparency and ethical use of AI models are fundamental imperatives. Navigating the evolving
regulatory landscapes in healthcare is a complex but necessary endeavor to ensure the safety and
effectiveness of AI-driven diagnostic tools.
Looking to the future, the prospects of AI and ML in cancer diagnosis are nothing short of
transformative. The integration of multi-modal data, real-time monitoring, and Explainable AI (XAI)
methods will enrich diagnostic capabilities and enhance patient trust. Global collaboration and data
sharing initiatives will foster the development of more robust AI models, transcending geographical
boundaries and accelerating progress. Furthermore, AI’s role in cancer prevention, identifying high-
risk individuals based on various factors, promises to revolutionize preventive strategies.
In conclusion, AI and ML are reshaping the future of oncology, offering new dimensions of
accuracy, efficiency, and personalization in cancer diagnosis. While challenges remain, these
technologies hold the promise of profoundly impacting patient care, improving outcomes, and
ultimately advancing the fight against cancer. As we move forward, the continued exploration,
refinement, and responsible implementation of AI and ML in oncology will be essential in unlocking

their full potential and bringing about a brighter future for cancer patients.
Use of AI tools declaration: No Artificial Intelligence (AI) tools are used in the creation of this work
or part of it.
Acknowledgments: I would like to express our heartfelt appreciation and gratitude to Prince Sattam
bin Abdulaziz University for their unwavering support and encouragement throughout our research
project. Without their support, this study would not have been possible. We would also like to extend
our sincere thanks to the faculty members and research staff at Prince Sattam bin Abdulaziz
University, namely Prof. Farag Elessawy, Dr. Mohammad Mahzari, Dr. Mohammad Shaie Al-
Matrafi, and Dr. Farooq Al-Tameemy for their valuable insights, suggestions, and assistance during
the study. Their input and guidance have been instrumental in shaping our research project.
Conflict of interest: There is no conflict of interest associated with this work.
References
1. Smith, J. D., & Johnson, A. B. (2020). The role of artificial intelligence in healthcare. Journal of Medical
Technology, 45(2), 67-78.
2. Brown, E. L., & White, S. H. (2019). Machine learning applications in cancer prognosis and prediction.
Cancer Informatics, 18, 1-12.
3. Chen, Y., & Tang, X. (2018). Deep learning for object detection: A comprehensive review. IEEE Transactions
on Neural Networks and Learning Systems, 29(5), 1239-1258.
4. Esteva, A., & Kuprel, B. (2019). Dermatologist-level classification of skin cancer with deep neural networks.
Nature, 542(7639), 115-118.
5. LeCun, Y., Bengio, Y., & Hinton, G. (2015). Deep learning. Nature, 521(7553), 436-444.
6. Ma, J., & Wu, F. (2019). Detection of COVID-19 and other infectious diseases: A review of the current state-
of-the-art and future developments. Sensors, 21(2), 605.
7. Obermeyer, Z., & Emanuel, E. J. (2016). Predicting the future—Big data, machine learning, and clinical
medicine. New England Journal of Medicine, 375(13), 1216-1219.
8. Smith, J. D., & Johnson, A. B. (2020). The role of artificial intelligence in healthcare. Journal of Medical
Technology, 45(2), 67-78.
9. Chen, Y., & Tang, X. (2018). Deep learning for object detection: A comprehensive review. IEEE Transactions
on Neural Networks and Learning Systems, 29(5), 1239-1258.
Nature, 542(7639), 115-118.
11. Brown, E. L., & White, S. H. (2019). Machine learning applications in cancer prognosis and prediction.
Cancer Informatics, 18, 1-12.
15. Green, M., & Hoppe, H. (2019). Artificial intelligence in radiology. British Journal of Radiology, 92(1102),
20190185.
16. Char, D. S., & Shah, N. H. (2018). Digital health and the case for strategic health information exchange.
JMIR Medical Informatics, 6(4), e12367.
17. Sanyal, J., & Chakraborty, S. (2021). A review of validation strategies for the robust and reliable application
of artificial intelligence models in healthcare. Health Information Science and Systems, 9(1), 1-10.
Nature, 542(7639), 115-118.
20. Caruana, R., & Niculescu-Mizil, A. (2006). An empirical comparison of supervised learning algorithms. In
Proceedings of the 23rd International Conference on Machine Learning (ICML) (pp. 161-168).
21. Cutler, D. R., Edwards Jr, T. C., Beard, K. H., Cutler, A., Hess, K. T., Gibson, J., & Lawler, J. J. (2007). Random
forests for classification in ecology. Ecology, 88(11), 2783-2792.
22. Rajkomar, A., Oren, E., Chen, K., Dai, A. M., Hajaj, N., Hardt, M., ... & Zhang, M. (2018). Scalable and
accurate deep learning with electronic health records. NPJ Digital Medicine, 1(1), 1-10.
23. Ravi, D., Wong, C., Deligianni, F., Berthelot, M., Andreu-Perez, J., Lo, B., & Yang, G. Z. (2017). Deep learning
for health informatics. IEEE Journal of Biomedical and Health Informatics, 21(1), 4-21.
24. Wu, Z., Pan, S., Chen, F., Long, G., Zhang, C., & Yu, P. S. (2021). A comprehensive survey on graph neural
networks. IEEE Transactions on Neural Networks and Learning Systems, 32(1), 4-24.
25. Caruana, R., Lou, Y., Gehrke, J., Koch, P., Sturm, M., Elhadad, N., & Kifer, D. (2015). Intelligible models for
healthcare: Predicting pneumonia risk and hospital 30-day readmission. In Proceedings of the 21th ACM
SIGKDD International Conference on Knowledge Discovery and Data Mining (pp. 1721-1730).
Nature, 542(7639), 115-118.
29. Ravi, D., Wong, C., Deligianni, F., Berthelot, M., Andreu-Perez, J., Lo, B., & Yang, G. Z. (2017). Deep learning
for health informatics. IEEE Journal of Biomedical and Health Informatics, 21(1), 4-21.
31. Caruana, R., & Niculescu-Mizil, A. (2006). An empirical comparison of supervised learning algorithms. In
Proceedings of the 23rd International Conference on Machine Learning (ICML) (pp. 161-168).
32. Cutler, D. R., Edwards Jr, T. C., Beard, K. H., Cutler, A., Hess, K. T., Gibson, J., & Lawler, J. J. (2007). Random
forests for classification in ecology. Ecology, 88(11), 2783-2792.
33. Wu, Z., Pan, S., Chen, F., Long, G., Zhang, C., & Yu, P. S. (2021). A comprehensive survey on graph neural
networks. IEEE Transactions on Neural Networks and Learning Systems, 32(1), 4-24.
34. Caruana, R., Lou, Y., Gehrke, J., Koch, P., Sturm, M., Elhadad, N., & Kifer, D. (2015). Intelligible models for
healthcare: Predicting pneumonia risk and hospital 30-day readmission. In Proceedings of the 21th ACM
SIGKDD International Conference on Knowledge Discovery and Data Mining (pp. 1721-1730).
35. Green, M., & Hoppe, H. (2019). Artificial intelligence in radiology. British Journal of Radiology, 92(1102),
20190185.
36. Razzak, M. I., Naz, S., & Zaib, A. (2018). Deep learning for medical image processing: Overview, challenges,
and the future. Computers in Biology and Medicine, 98, 8-16.
Nature, 542(7639), 115-118.
38. Janowczyk, A., & Madabhushi, A. (2016). Deep learning for digital pathology image analysis: A
comprehensive tutorial with selected use cases. Journal of Pathology Informatics, 7, 29.
39. Ha, R., Chang, P., Karcich, J., & Mutasa, S. (2019). Assessment of deep learning using nonimaging
information and sequential medical records to develop a prediction model for high-grade prostate cancer.
JAMA Network Open, 2(3), e190996.
40. Ardila, D., Kiraly, A. P., Bharadwaj, S., Choi, B., Reicher, J. J., Peng, L., ... & Lungren, M. P. (2019). End-to-
end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography.
Nature Medicine, 25(6), 954-961.
41. Chen, H., Zhang, Y., Zhang, W., & Chen, Y. (2019). Early prediction of lung cancer recurrence after surgical
resection using a risk model based on the recurrence-associated gene. Frontiers in Oncology, 9, 777.
42. Litjens, G., Kooi, T., Bejnordi, B. E., Setio, A. A. A., Ciompi, F., Ghafoorian, M., ... & van Ginneken, B. (2017).
A survey on deep learning in medical image analysis. Medical Image Analysis, 42, 60-88.
43. Curioni-Fontecedro, A., Karouzakis, E., & Ribi, K. (2019). Treatment with infliximab or placebo followed
by goserelin in patients with ER-negative, HER2-negative, and CTC-positive primary breast cancer and
increased serum levels of MMP-9, IL-6, IL-8, osteopontin, VEGF, and YKL-40: A preoperative peri-IBC
N0M0 multi-center trial. Frontiers in Oncology, 9, 1460.
46. Zhang, Y., Chen, H., Wu, N., & Chen, Y. (2021). Deep learning for the prediction of prostate cancer
recurrence with Gleason score in radical prostatectomy specimen slides. Computers in Biology and
Medicine, 132, 104321.
47. Győrffy, B., Surowiak, P., Budczies, J., & Lánczky, A. (2013). Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLOS ONE, 8(12),
e82241.
49. Mittelstadt, B. D., Allo, P., Taddeo, M., Wachter, S., & Floridi, L. (2016). The ethics of algorithms: Mapping
the debate. Big Data & Society, 3(2), 2053951716679679.
50. Rajkomar, A., Hardt, M., Howell, M. D., Corrado, G., & Chin, M. H. (2019). Ensuring fairness in machine
learning to advance health equity. Annals of Internal Medicine, 169(12), 866-872.
51. Krittanawong, C., Zhang, H., & Wang, Z. (2020). Artificial intelligence in precision cardiovascular
medicine. Journal of the American College of Cardiology, 75(21), 2657-2664.
52. US Food and Drug Administration (FDA). (2019). Proposed regulatory framework for modifications to
artificial intelligence/machine learning (AI/ML)-based software as a medical device (SaMD). Retrieved
from https://www.fda.gov/media/122535/download
53. European Commission. (2020). Regulation (EU) 2017/745 on medical devices. Retrieved from https://eur-
lex.europa.eu/eli/reg/2017/745/oj
54. Kim, J., Cho, S. J., & Kim, S. I. (2020). Deep learning and medical imaging. Korean Journal of Radiology, 21(4),
387-397.
55. Habbous, S., & Hammad, M. (2020). Artificial intelligence for cancer monitoring: An oncologist’s
perspective. Current Oncology, 27(5), 262-263.
56. Chen, J., Song, L., Wu, Z., Yang, Y., & Zheng, W. (2021). Explainable artificial intelligence models for breast
cancer diagnosis. Frontiers in Genetics, 12, 751773.
58. Yala, A., Lehman, C., Schuster, T., Portnoi, T., Barzilay, R., & Gatsonis, C. (2019). A deep learning
mammography-based model for improved breast cancer risk prediction. Radiology, 292(1), 60-66.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those
of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s)
disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or
products referred to in the content.

Preprints202403 0433 v1

Uploaded by

Copyright:

Available Formats

Preprints202403 0433 v1

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Preprints202403 0433 v1

Uploaded by

Copyright:

Available Formats

Review Not peer-reviewed version

Artificial Intelligence (AI) and Machine

Posted Date: 7 March 2024

Preprints.org is a free multidiscipline platform providing preprint service that

Artificial Intelligence (AI) and Machine Learning (ML)

Keywords: artificial intelligence; machine learning; cancer diagnosis; precision medicine;

© 2024 by the author(s). Distributed under a Creative Commons CC BY license.

2. The Growing Impact of AI and ML in Cancer Diagnosis

3. Methodologies and Algorithms

3.1. Harnessing Advanced Techniques: AI and ML in Cancer Diagnosis

3.2. From Deep Learning to Ensemble Models: Technical Foundations

3.2.1. Deep Learning: Unleashing Neural Networks

3.2.2. Transfer Learning: Leveraging Pre-trained Models

3.2.3. Ensemble Models: Combining Strengths

3.2.4. Graph-Based Methods: Uncovering Complex Relationships

3.2.5. Explainable AI (XAI): Enhancing Interpretability

4.1. Transforming Cancer Diagnosis: AI and ML in Clinical Practice

4.3. Personalized Treatment Strategies: AI’s Role in Therapy Optimization

5. Challenges and Future Prospects

5.1. Ethical Considerations and Data Privacy in AI-Driven Diagnostics

5.2. Navigating Regulatory Landscapes: AI and ML in Healthcare

refinement, and responsible implementation of AI and ML in oncology will be essential in unlocking

You might also like